Work

P14.04 A Phase 2 Multicenter Study of Iovance Autologous Tumor Infiltrating Lymphocytes (TIL, LN-145) Cell Therapy in Patients With Metastatic NSCLC

Year: 2021

Type: conference-abstract

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2021.08.334

Authors: E. Massarelli, A. Schoenfeld, J. Chesney, Y. Hong, P. Lammers, J. Nieva, T. Wise-Draper, Z. Goldberg, A. Cacovean, B. Yadav, G. Chen, M. Jagasia, F. Graf Finckenstein, M. Fardis, A. Sukari

Institutions: City Of Hope National Medical Center, City of Hope, Memorial Sloan Kettering Cancer Center, University of Louisville, Cooper University Hospital, USC Norris Comprehensive Cancer Center, University of Cincinnati, Iovance Biotherapeutics (United States), Wayne State University, The Barbara Ann Karmanos Cancer Institute

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W3205270945

Cites:

Cited by:

Related to: 10